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Abstract
Background: Synaptic dysfunction, named synaptopathy, due to inflammatory status of the central nervous system
(CNS) is a recognized factor potentially underlying both motor and cognitive dysfunctions in neurodegenerative
diseases. To gain knowledge on the mechanistic interplay between local inflammation and synapse changes, we
compared two diverse inflammatory paradigms, a cytokine cocktail (CKs; IL-1β, TNF-α, and GM-CSF) and LPS, and
their ability to tune GABAergic current duration in spinal cord cultured circuits.
Methods: We exploit spinal organotypic cultures, single-cell electrophysiology, immunocytochemistry, and confocal
microscopy to explore synaptic currents and resident neuroglia reactivity upon CK or LPS incubation.
Results: Local inflammation in slice cultures induced by CK or LPS stimulations boosts network activity; however,
only CKs specifically reduced GABAergic current duration. We pharmacologically investigated the contribution of
GABAAR α-subunits and suggested that a switch of GABAAR α1-subunit might have induced faster GABAAR decay
time, weakening the inhibitory transmission.
Conclusions: Lower GABAergic current duration could contribute to providing an aberrant excitatory transmission
critical for pre-motor circuit tasks and represent a specific feature of a CK cocktail able to mimic an inflammatory
reaction that spreads in the CNS. Our results describe a selective mechanism that could be triggered during specific
inflammatory stress.
Keywords: Organotypic spinal slices, Patch-clamp, Synaptic currents, Neuroinflammation, GABAergic inhibition,
GABAergic receptors, Spinal circuits, NKCC1, Resident neuroglia
Background
Neuroinflammation is a characterizing trait of various
central nervous system (CNS) pathologies, from neuro-
degenerative diseases to neuropsychiatric disorders [1].
Currently, intense research efforts are dedicated to the
understanding of how the different signaling pathways,
activated in neurons and neuroglia by the inflammatory
milieus, may ultimately promote synaptic dysfunction
[2–4]. For example, several studies documented, in the
interplay between the immune system and neuronal func-
tion, the involvement of pro-inflammatory cytokines
(CKs), such as TNF-α, IL-1β, and IL-6 [5–7]. Similarly,
lipopolysaccharide (LPS, an endotoxin derived from gram-
negative bacteria)-induced neuroinflammation may lead
to synaptic dysfunctional signaling contributing signifi-
cantly to cognitive disturbances [8]. In contrast to the gen-
eral agreement on the emergence of synaptopathy due to
inflammation [2], the rules governing the specific neuro-
transmission systems involved, and their tuning, are un-
clear. Conflicting evidence indicate that exogenous CK
applications may increase [9] or decrease [10] glutamatergic
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: clara.ballerini@unifi.it; laura.ballerini@sissa.it
4Dipartimento di Medicina Sperimentale e Clinica, University of Florence,
50139 Florence, Italy
1International School for Advanced Studies (SISSA/ISAS), 34136 Trieste, Italy
Full list of author information is available at the end of the article
Giacco et al. Journal of Neuroinflammation          (2019) 16:127 
https://doi.org/10.1186/s12974-019-1519-z
synaptic transmission, as well as for GABAergic transmis-
sion, where both decreases [11, 12] and increases [13, 14]
are reported.
With the aim of dissecting the impact of immune sta-
tus alterations on neural circuit function, we focused our
study on the effects of local inflammation in a controlled
micro-environment where neurons and neuroglial cells
maintain appropriate organization: the organotypic slice
cultures developed from the embryonic mouse spinal
cord. In this complex in vitro model, the sensory-motor
cytoarchitecture, synaptic properties, and spinal cord
resident cells are retained in a 3D-fashion [15–17]. By
the use of this model, we preliminarily reported the
emergence of synaptopathy in pre-motor circuits follow-
ing CK transient exposure, characterized by a speeding
up of the decay phase of GABAergic inhibitory currents
[17]. A broader question is to what extent the tuning of
GABAergic current duration may occur as a response to
any local alteration in the inflammatory status of the
spinal cord, disrupting physiological excitability levels,
being GABAergic neurotransmission an important de-
terminant of spinal circuit coordination [18].
In the present study, we compare the effects on syn-
aptic transmission of different experimental inflamma-
tory models, LPS, a potent trigger of cytokine induction
[19, 20] and the most common stimulus used to inves-
tigate microglial reactivity in brain inflammation, and a
pro-inflammatory cocktail containing interleukin-1β
(IL-1β), well-known determinant of neuropathy [1, 2],
tumor necrosis factor α (TNF-α), present during Th1/
Th17-mediated inflammatory reactions, and granulo-
cyte macrophage-colony stimulating factor (GM-CSF),
targeting resident microglial cells. These cytokines are
key factors known to affect neuronal functions and re-
sponsible for pro-inflammatory effects in the CNS of
multiple sclerosis animal models [21]. We adopted rela-
tively acute treatments (hours), known to trigger in-
flammatory responses, without inducing direct
neurotoxicity, yet still able to alter synaptic transmis-
sion [17]. Thus, organotypic spinal cord cultures were
transiently exposed to pro-inflammatory CK cocktail
(TNF-α, IL-1β, and GM-CSF, 4 and 6 h; [17]) or to LPS
(4, 6, and 24 h).
To compare CKs and LPS impact on synaptic activ-
ity, in particular on GABAergic currents, we used
single-cell patch-clamp recordings. We further explore
by immunofluorescence and confocal microscopy resi-
dent neuroglia reactivity, and we measure the local
production of cytokines and chemokines in response
to the two inflammatory stresses. CKs and LPS sig-
nificantly increase the generation of these signaling
proteins, and both danger signals boost basal synaptic
activity, inducing a distinct transformation of resident
neuroglia morphology. To note, only CKs promote
changes in inhibitory transmission time course. Fi-
nally, we investigated the mechanisms responsible for
the shortening of GABAergic current duration upon
CK treatment, since these may emerge as potential
targets for novel therapeutics.
Methods
Organotypic spinal cord cultures, pro-inflammatory
treatments, and pharmacology
All experiments were performed in accordance with
the EU guidelines (2010/63/UE) and Italian law (De-
cree 26/14) and were approved by the local authority
veterinary service and by our institution (SISSA) eth-
ical committee. All efforts were made to minimize
animal suffering and to reduce the number of animals
used. Animal use was approved by the Italian Minis-
try of Health, in agreement with the EU Recommen-
dation 2007/526/CE.
Organotypic spinal cord and dorsal root ganglia
(DRG) slices were obtained from mouse embryos
(C57BL/6 J) at E12-13 of gestation as previously de-
scribed [15–17, 22]. Briefly, pregnant mice were sacri-
ficed by CO2 overdose and fetuses delivered by
cesarean section. Isolated fetuses were decapitated,
and their backs were isolated from low thoracic and
high lumbar regions and transversely sliced (275 μm)
with a tissue chopper. After dissecting the spinal cord
slices and the DRG from the surrounding tissue,
slices were embedded into a thick matrix obtained by
chicken plasma (Rockland) and thrombin (Sigma) clot.
Slices were cultured in plastic tubes with 1 mL
medium. The tubes were kept in a roller drum rotat-
ing 120 times per hour in an incubator at 37 °C in
the presence of humidified atmosphere, with 5% CO2.
Experiments were performed on spinal cultures at
14–21 days in vitro (DIV). The day of the experiment,
organotypic slices were incubated with standard medium
(control) or, for 4 or 6 h (4H and 6H), with two different
inflammatory paradigms: (i) a cocktail of the mouse re-
combinant cytokines (10 ng/mL each) TNF-α (R&D Sys-
tems, #210-TA/CF), IL-1β (R&D Systems, #M15330), and
granulocyte-macrophage colony-stimulating factor (GM-
CSF; R&D Systems, #P04141; [17, 23]); (ii) lipopolysac-
charide (LPS; 1 μg/mL, Sigma, O55:B5). For LPS, we also
tested a longer incubation time point (24H). CKs or LPS
were removed after the incubation times, prior to electro-
physiological recordings.
Bumetanide (Sigma) was diluted in phosphate buffer
solution (PBS 1×, Sigma) and used to block the Na+/K+/
Cl− co-transporter (NKCC1; [24]). To decrease the cyto-
plasmic chloride concentration, slices were incubated for
24 h at 37 °C with 10 μM bumetanide (BUM24H), after
24H, the CK cocktail was added for additional 4 h
(BUM24H + CKs4H).
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Immunofluorescence, imaging, and analysis
Organotypic cultures were fixed with 4% formaldehyde
(prepared from fresh paraformaldehyde; Sigma) in PBS (1×)
for 1 h at room temperature (RT; 20 to 22 °C) and washed
in PBS. Free aldehyde groups were quenched in 0.1M gly-
cine in PBS for 10min. Slices were permeabilized and
blocked in PBS 1×, 5% FBS (Sigma), 1% BSA (Sigma), and
0.3% Triton X-100 (Sigma) at RT for 1 h and then incu-
bated overnight at 4 °C with anti-GFAP (mouse monoclo-
nal, 1:400, Sigma), anti-Iba1 (rabbit polyclonal, 1:200,
Wako), anti-SMI32 (mouse monoclonal, 1:200, EMD-
Millipore), and anti-MAP 2 (mouse monoclonal, 1:200,
Sigma) primary antibodies.
For β-tubulin III and GAD65/67 co-immuno-labeling,
fixed samples were quenched with Na-(meta) periodate
2.3% in deionized water for 5min and Na-borohydride 1%
in TRIS 0.1M for 10min. Slices were blocked in free-
floating with PBS 1×, 10% FBS (Sigma), 1% BSA (Sigma),
1% fish gelatin (Sigma), and 0.3% Triton X-100 (Sigma) at
RT for 1 h and then incubated overnight at 4 °C with anti-
β-tubulin III primary antibody (mouse monoclonal; 1:500,
Sigma) and anti-GAD65/67 (rabbit polyclonal; 1:500,
ABCAM).
Subsequently, the slices were PBS-washed and incu-
bated with secondary antibodies diluted in blocking solu-
tion for 2 h at RT in the dark. The secondary antibodies
were Alexa 488 goat anti-mouse (1:500, Invitrogen), Alexa
488 goat anti-rabbit (1:500, Invitrogen), Alexa 594 goat
anti-mouse (1:500, Invitrogen), Alexa 594 goat anti-rabbit
(1:500, Invitrogen), and DAPI (Thermo Fisher Scientific).
Samples were mounted on glass coverslips using Vecta-
shield mounting medium (Vector Laboratories).
Images were acquired using Nikon C2 confocal micro-
scopes with Ar/Kr, He/NE, and UV laser with × 20, × 40, or
× 63 oil objectives (1.4 N.A.) using oil mounting medium
(1.515 refractive index). Confocal sections were acquired
every 0.5 μm up to a total Z-stack thickness of 5 μm. For
each condition, we performed > 3 and < 6 independent cul-
tures; from each culture series, we used 4 slices, and from
each slice, ≥ 5 fields were randomly acquired. Offline ana-
lysis of the image Z-stack was performed using the open
source image-processing package FIJI (http://fiji.sc/Fiji).
For the quantitative analysis of microglia morph-
ology, we used the particle measurement feature in
ImageJ, to automatically measure the area and the
perimeter, necessary to calculate the transformation
index [25], as ½perimeter of cell ðμmÞ
2
4π∙½area of cell ðμm2Þ , which defines micro-
glia ramification status. Indeed, cells with long pro-
cesses and small soma show a large index that
depends on cell shape, regardless of the cell size.
Quantification of GAD65/67 immunoreactivity was
performed measuring the intensity of fluorescence and
the number of GAD65/67 clusters using the Volocity3D
Image Analysis Software. Clusters were determined after
thresholding of images. Thresholds were determined
using the “voxel spy” facility of the software and chosen
such that all recognizable punctuate structures were in-
cluded into the analysis (size > 0.03 μm3 and separate
touching objects of 0.5 μm3).
Electrophysiological recordings and data analysis
For patch-clamp recordings (whole-cell, voltage clamp
mode), a coverslip with the spinal culture was positioned
in a recording chamber, mounted on an inverted micro-
scope (Nikon Eclipse TE200) and superfused with a
standard saline solution containing (mM) 152 NaCl, 4
KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, and 10 glucose; the
pH was adjusted to 7.4 by NaOH (305 mOsm). Patch pi-
pettes were pulled from borosilicate glass capillaries (4
to 7MΩ) and filled with intracellular solution containing
(mM) 120 K gluconate, 20 KCl, 10 HEPES, 10 EGTA, 2
MgCl2, and 2 Na2ATP. The pH was adjusted to 7.3 with
KOH (295 mOsm). All electrophysiological recordings
were performed at RT. The reported voltage values are
corrected for the liquid junction potential (− 14mV)
[26]. Electrophysiological responses were amplified
(EPC-7, HEKA), sampled, and digitized at 10 kHz with
the pCLAMP software (Axon Instruments) for offline
analysis. The value of series resistance was < 10MΩ en-
abling recordings of synaptic currents without significant
distortion and thus was not compensated for [16, 26].
Recordings were performed from ventrally located spinal
interneurons visually identified based on previously re-
ported criteria [27]. Spontaneous post-synaptic currents
(PSCs) were recorded at − 70 mV holding potential by
the Clampfit 10 software (pClamp suite, Axon Instru-
ments). On average, ≥ 400 events were analyzed from
each cell in order to obtain mean kinetic and amplitude
parameters. From the average of these events, we mea-
sured the rise time defined as the 10–90% time needed
to reach the peak of the synaptic current, the peak amp-
litude, and the decay time constant (τ) that was obtained
by fitting a mono-exponential function [27].
We compared the passive membrane properties among
control and CK- and LPS-treated spinal interneurons. We
detected no differences in cell capacitance (51 ± 31 pF
control; 43 ± 23 pF CKs 4H; 43 ± 21 pF CKs 6H; n = 62,
47, 54 respectively; 55 ± 23 pF control; 44 ± 18 pF LPS 4H;
48 ± 22 pF LPS 6H; n = 35, 38, 34, respectively) and input
resistance (470 ± 195MΩ control; 587 ± 137MΩ CKs 4H;
481 ± 114MΩ CKs 6H; 430 ± 123MΩ control; 399 ± 121
MΩ LPS 4H; 439 ± 146MΩ LPS 6H).
Inhibitory GABAergic post-synaptic currents (IPSCs)
were recorded at − 84mV holding potential in the pres-
ence of CNQX (10 μM; Sigma), strychnine (1 μM; Sigma),
and APV (25 μM; Sigma). Tetrodotoxin (TTX; 1 μM,
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Latoxan) was used to isolate GABAA-receptor-mediated
miniature events (mIPSCs).
Recordings of the IPSCs at different holding potentials
were used to measure the chloride equilibrium potential
(ECl), which was determined as the x-axis intercept point of
the resulting I/V curve extrapolated by linear regression.
The imidazopyridine zolpidem (zolpidem, Sigma), a
benzodiazepine ligand with high selectivity for GABAARs
containing the α1-subunit and moderate affinity to α2- or
α3-subunit, [28], was dissolved in water stock solution (1
mM) and diluted to the concentration of 100 nM [29] in
extracellular solution for bath application (15–20min).
Cytokine and chemokine measurement
TNF-α, IL-4, IL-6, IL-10, INF-γ, CXCL1, and CXCL2 con-
centrations were measured in organotypic culture superna-
tants by Milliplex assay (Merck Millipore, #MCYTOMAG-
70 k), using the Bio-Plex apparatus (Biorad), according to
the manufacturer’s recommendations.
Statistical analysis
All values from samples subjected to the same experimen-
tal protocols were pooled together, and results are pre-
sented as mean ± S.D., if not stated otherwise, with n =
number of neurons. A statistically significant difference
between two data sets was assessed by Student’s t test
(after checking variances homogeneity by Levene’s test)
for parametric data and by Mann-Whitney’s test for non-
parametric ones. Two-way analysis of variance (two-way
ANOVA) and one-way ANOVA were used for parametric
data or Kruskal-Wallis test for non-parametric ones, to
determine significance when multiple groups were com-
pared. Statistical significance was determined at P < 0.05.
In box plots, the thick horizontal bar indicates the me-
dian value, the cross indicates the mean value, the boxed
area extends from the 25th to 75th percentiles while
whiskers from the 5th to the 95th percentiles.
Results
CKs but not LPS regulate GABAA receptor-mediated
synaptic currents in spinal organotypic cultures
We used organotypic spinal cord and DRG co-cultures
(Fig. 1a) to study the impact of neuroinflammation on the
GABAergic synaptic transmission within ventral horn pre-
motor circuits [16]. Two different danger signals were used
to trigger neuroinflammation in cultured slices: a pro-
inflammatory cocktail of CKs [17] and LPS [19]. In both
conditions, after 4H and 6H treatments (see the “Methods”
section), patched clamped ventral interneurons displayed a
significant increase in the frequency of spontaneous PSCs
(represented by heterogeneous inward currents of variable
amplitudes, see Additional file 2: Figure S1 A–D) in accord-
ance with previous reports [5, 17, 30, 31].
Since fast Cl−-mediated neurotransmission is a poten-
tial pro-inflammatory cytokine target in spinal circuits
[5, 17, 32], we recorded GABAA receptor-mediated syn-
aptic events (IPSCs; Fig. 1b) pharmacologically isolated
in the presence of CNQX (10 μM), APV (25 μM), and
strychnine (1 μM), to block AMPA, NMDA, and glycine
receptor-mediated synaptic currents [17]. CK and LPS
treatments increased IPSC frequency, without altering
IPSC amplitudes (sample tracings in Fig. 1b and box
plots in Additional file 3: Figure S2 A and B), when com-
pared to control.
We next explored the kinetic properties of the IPSCs.
Consistent with our preliminary findings [17], CK treat-
ments (4H and 6H, n = 33 and 37, respectively) signifi-
cantly accelerated the IPSC decay time constant (τ)
(23.7 ± 6.5 ms CKs 4H; 25.7 ± 6.6 ms CKs 6H; Fig. 1c,
top, box plot and scaled averaged IPSCs are superim-
posed in the inset) when compared to control (31.5 ±
9.6 ms control, n = 40; ***P < 0.001 control vs CKs 4H,
**P = 0.004 control vs CKs 6H; Fig. 1c). Conversely, LPS
(4H and 6H, n = 34 and 28, respectively) left the τ of the
IPSCs unchanged (27.9 ± 7.1 ms LPS 4H; 28.1 ± 6.3 ms
LPS 6H) in respect to control (29.1 ± 7.4 ms control, n =
37; Fig. 1c, bottom box plot and scaled averaged IPSCs
are superimposed in the inset). The IPSC rise-time
values (Additional file 3: Figure S2 C) were unaffected
by all treatments. Since IPSC decay time may be devel-
opmentally regulated [32], we plotted the τ values de-
tected in control and in CKs 4H and 6H against two
time of growth in vitro. Bar plots in Fig. 1d show that
CKs shortened the GABAergic current duration at any
age of maturation in vitro, thus excluding a correlation
between the CK modulation of IPSC decay time and the
developmental stage of spinal cord slices in vitro.
We extended our characterization to the properties of
miniature GABAergic currents (mPSCs; recorded in the
presence of TTX). The results in this group of cells
(Fig. 1e) confirmed that CKs affected mPSC decay kinet-
ics (mPSCs τ value 40.9 ± 11.7 ms in control; 29.4 ± 11.6
ms in CKs 4H; 24.3 ± 6.4 ms in CKs 6H; n = 9, 7, 9, re-
spectively; *P = 0.024 control vs CKs 6H) with a trend
similar to that of spontaneous IPSCs. mIPSC decay time
remained unchanged upon LPS treatments (30.2 ± 5.9
ms control; 29.3 ± 4.3 ms LPS 4H; 30.2 ± 5.3 ms LPS 6H;
n = 5, 5, 5, respectively; Fig. 1e, bottom) in accordance
with the spontaneous IPSCs.
We next examined by immunofluorescence the pres-
ence and distribution of GABAergic neurons in spinal
ventral horns, targeting either isoforms of GABA-
synthesizing enzyme (glutamate decarboxylase, GAD),
namely GAD65/67 [33]. We quantified and compared
GAD65/67 labeling in all conditions (Additional file 4:
Figure S3, A–D). Immunoreactivity for GAD65/67 was
visible throughout the spinal explants where neurons
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were visualized using a specific marker (class III β-
tubulin, Additional file 4: Figure S3 A and C). At lower
magnification, scattered soma, extensive neural processes,
and bouton-like structures (named clusters, see the
“Methods” section) appeared to be stained for both GAD
isoforms and were not affected by CK or LPS treatments,
quantified in Additional file 4: Figure S3 B and D.
Resident neuroglia reactivity to CKs and LPS in spinal
organotypic slices
In response to different microenvironment stimuli, micro-
glia and astrocytes may switch to active states, highlighted
by changes in cell function, number, and/or morphology.
Microglia and astrocytes were visualized in organotypic
spinal explants by Iba1 and GFAP co-immunolabeling,
shown in Fig. 2 a and b.
CKs 4H and 6H promoted a significant increase in
Iba1+ cells (99.8 ± 5.5 cells/mm2 control; 155.3 ± 21.5
cells/mm2 CKs 4H; 183.7 ± 15.7 cells/mm2 CKs 6H;
*P = 0.032 control vs CKs 4H; ***P < 0.001 control vs
CKs 6H; summarized in Additional file 1: Table S1
for 4H and in Fig. 2c, left, for 6H). The same treat-
ments promptly induced a significant increase in
GFAP intensity (158.1 ± 35.7% CKs 4H; 229.3 ± 37.3%
CKs 6H; *P = 0.024 control vs CKs 4H, ***P < 0.001 vs
CKs 6H; ***P < 0.001 CKs 4H vs CKs 6H; summarized
in Additional file 1: Table S1 for 4H and Fig. 2c,
right, for 6H). Differently, LPS, summarized for 4H in
Additional file 1: Table S1 and in the plots in Fig. 2d
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Fig. 1 Cytokines affect GABAergic synaptic current kinetics in organotypic spinal culture. a Low magnification micrograph of immunofluorescence
labeling of organotypic spinal cord slice (14 DIV), SMI-32 (in red), and MAP 2 (in green) markers identify axons and mature neurons. The ventral area
(localized by the ventral fissure, arrow) highlighted by the dashed square is shown at higher magnification in the right panels. VH = ventral horn, DH =
dorsal horn, DRG= dorsal root ganglia. b Pharmacologically isolated IPSCs recorded from ventral interneurons at 14 DIV. Control current tracings are in
black. CKs 4H (in gray) and 6H (in blue) (left) and LPS 4H (in gray) and 6H (in blue) (right) increased IPSC frequency. c Box plots summarize the decay
time constant (τ) values of IPSCs from pooled experiments in CKs (top) or LPS (bottom); the insets show superimposed and scaled IPSC average
tracings (same cells as in b); note the changes in IPSC duration in CKs (**P < 0.01; ***P < 0.001, one-way ANOVA). d Bar plot (mean ± SEM) of IPSCs τ
values plotted against DIV; bins are at 13–15 DIV: 36.3 ± 2.7ms control; 26.5 ± 2.2 ms CKs 4H; 24.5 ± 1.6ms CKs 6H; n = 14, 10, 15, respectively; *P = 0.011
control vs CKs 4H; ***P < 0.001 control vs CKs 6H; bins at 20–22 DIV: 37.6 ± 3.6ms control; 22.5 ± 2.6ms CKs 4H; 26.2 ± 2.9 ms CKs 6H; n = 8, 6, 6,
respectively; *P = 0.011 control vs CKs 4H; *P = 0.041 control vs CKs 6H (one-way ANOVA). e Box plots summarize the τ values of mIPSCs from pooled
experiments in CKs (top) or LPS (bottom), note the changes in mIPSC duration in CKs. *P = 0.024 control vs CKs 6H, one-way ANOVA
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for 6H, provoked only mild increases in Iba1+ cells
(100.8 ± 8.2 cell/mm2 control; 112.8 ± 7.4 cell/mm2
LPS 4H; 132.2 ± 11.7 cell/mm2 LPS 6H) and in the
GFAP intensity (110.4 ± 18.7% LPS 4H; 141.1 ± 15.1%
LPS 6H).
We further assessed CK and LPS ability to shape the
morphology of Iba1+ microglia at 6H. To this aim, we
quantified the total dendrite length [34] together with the
transformation index (results summarized in Fig. 3a, b;
[25]). Upon CKs 6H treatments, microglia showed a sig-
nificant decrease in both the total dendrite lengths
(270.3 ± 144.8 μm control; 93.8 ± 81.2 μm CKs 6H; ***P <
0.001 control vs CKs 6H) and the transformation index
(2.7 ± 2.4 control; 1.7 ± 0.7 CKs 6H; **P < 0.005 control vs
CKs 6H). In parallel, in slices stimulated by LPS, we ob-
served, at 6H, changes in microglia morphology that seem
to indicate a different stage of activation [35]. In fact, Fig. 3
a and b show a significant increment of the Iba1+ cell den-
drite length at LPS 6H (346.6 ± 194.9 μm control; 472.6 ±
255.9 μm LPS 6H; ***P < 0.001 control vs LPS 6H) and of
the transformation index (7.2 ± 5.3 control; 12.2 ± 7.7 LPS
6H; ***P < 0.001 control vs LPS 6H). Finally, we evaluated
and compared the production of cytokines and chemo-
kines by spinal slices in response to pro-inflammatory
stress at 6H (for CKs n = 14 slices and for LPS n = 22
slices, from 3 different culture series). The summarizing
plots of Fig. 3c, d show that the exposure to CKs (c) and
LPS (d) significantly increased, although to a different ex-
tent, the release of pro-inflammatory cytokines, measured
in the supernatant, such as TNF-α, IL-6, and INF-γ, as
well as the release of chemokines including CXCL1 and
CXCL2 necessary for the recruitment of innate immune
cells. Interestingly, IL-4 and IL-10 are significantly raised
upon CK stimuli, but are not changed after LPS treat-
ments. The different pro- and anti-inflammatory cytokine
network, in addition to the production of chemokines,
suggests the induction of alternative activation mecha-
nisms in spinal slices stimulated by CKs and LPS at the
time point (6H) analyzed.
In the central nervous system, LPS binds to the Toll-
like receptors (TLRs), especially TLR4, expressed on the
microglia surface. This signal involves several proteins
resulting in the production and release of cytokines, che-
mokines, and other inflammatory factors [36]. Since
LPS, differently from CKs [37], may not act directly on
neurons, we tested whether a longer (24H) exposure to
LPS may ultimately lead to changes in GABAergic trans-
mission and kinetic. Figure 4 reports the effects of LPS
24H in terms of PSC frequency (21.7 ± 6.7 Hz control;
30.5 ± 5.0 Hz LPS 24H; n = 8 and 12, respectively; **P =
0.003 control vs LPS 24H; Fig. 4a), IPSC frequency
(1.2 ± 0.8 Hz control; 2.5 ± 0.9 Hz LPS 24H; **P = 0.007
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Fig. 2 CK and LPS modulation of resident microglia and astrocytes in organotypic spinal cultures. a, b Representative confocal images of
organotypic spinal slices immunolabeled for Iba1 (in red) and GFAP (in green), visualizing microglia and astrocytes, respectively, prior and after
CKs (in a) or LPS (in b) treatments (4H and 6H). c, d Bar plots summarize Iba1+ cells/mm2 and GFAP intensity (expressed as percentage of control)
prior and after CKs (6H; in c) or LPS (6H; in d) treatments. Bar plots (mean ± SEM); ***P < 0.001, one-way ANOVA
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control vs LPS 24H; Fig. 4b), and IPSC decay time con-
stant (32.7 ± 10.2 ms control; 29.7 ± 5.5 ms LPS 24H,
Fig. 4c, scaled averaged IPSCs are superimposed in the
inset). In addition, Iba1+ cells at LPS 24H (Fig. 4 D) dis-
played the characteristic morphology with longer
branching in ramified cells (quantified in plots of Fig. 4d,
total dendrites length: 249.6 ± 96.0 μm control; 393.4 ±
216.9 μm LPS 24H; ***P < 0.001 control vs LPS 24H;
transformation indices: 5.2 ± 3.1 control; 8.6 ± 7.1 LPS
24H). These results indicated that the kinetic of GABAer-
gic currents was not modulated by longer incubation in
this danger signal, and the effects on microglia dendrite
lengths stabilized after 6H.
CKs modulate GABAergic current duration through
changes in GABAAR subunits composition
We further explored the mechanisms responsible for
IPSC shortening due to CKs. The decay of IPSCs is also
faster, upon CK treatments, in unitary synaptic events
(mIPSCs), ruling out the involvement of presynaptic
processes affecting IPSC time course, such as neuro-
transmitter release synchronization. Moreover, the ab-
sence of changes in IPSC rise time (Additional file 3:
Figure S2 C) suggests that differences in recording con-
ditions, location of synapses or electronic filtering, are
unlikely to have affected our observations.
Differences in the intracellular chloride concentration
[Cl−]i were reported to affect IPSC kinetics [38, 39]. We
incubated organotypic slices with bumetanide (10 μM;
24H, n = 11), a blocker of NKCC1 activity [24], a
membrane-protein described as the most abundant co-
transporter determining intracellular chloride levels [40],
to experimentally reduce [Cl−]i prior to CKs 4H (n = 10;
see sketch of the experimental settings in Fig. 5a).
Bumetanide per se induced an increase in PSC and IPSC
frequencies that were slightly, although not significantly, fur-
ther improved by CKs 4H (Fig. 5b for sample tracings and
Additional file 5: Figure S4). More intriguingly, bumetanide
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Fig. 3 CKs and LPS induce opposite changes in microglia morphology. a Representative confocal images comparing Iba1 immunolabeling in
untreated (control) and CK- and LPS-treated (4H and 6H) cultures. b Box plots show pooled data from different experiments. Note the significant
decrease in total dendrites length and transformation indices upon CKs 6H (left); on the opposite, a significant increase in total dendrites length
and in the transformation indices is reported at LPS 6H (right). **P < 0.01, ***P < 0.001, Kruskal-Wallis test (Dunn’s post hoc test). c, d Production of
cytokines (TNF-α; IL-4; IL-6; IL-10; INF-γ) and chemokines (CXCL1; CXCL2) determined by Milliplex assay of organotypic culture supernatants after
incubation with CKs (c) and LPS (d) for 6H. Bar plot (mean ± SEM of 22 and 14 slices, respectively); **P < 0.01, ***P < 0.001, one-way ANOVA
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reduced significantly the duration of GABAergic currents
(τ = 33.1 ± 8.1ms control; τ = 22.3 ± 6.2ms BUM 24H;
**P = 0.005 control vs BUM 24H) that were not further
shortened by CKs 4H (τ= 22.3 ± 6.5ms BUM 24H + CKs
4H; *P= 0.012 control vs BUM 24H + CKs 4H; Fig. 5c).
Figure 5 d shows the measurement of the reversal poten-
tial of IPSCs in control, BUM 24H, and BUM 24H + CKs
4H. The estimated ECl value in control (− 48.5 ± 3.7mV;
n = 7) was close to the approximate theoretical value
expected for the Cl− equilibrium potential for our
A
C
D
B
Fig. 4 Long-term exposure to LPS in organotypic spinal slices is not altering GABAergic currents. a Representative traces of spontaneous PSCs
recorded from control (in black) and LPS 24H (in orange) ventral interneurons. The box plot shows a significant increase in PSC frequency upon
LPS 24H. **P = 0.003, Mann-Whitney test. b Pharmacologically isolated IPSCs are recorded from control (in black) and LPS 24H (in orange) ventral
interneuron (same cells as in a). The box plot summarizes the IPSC frequency from pooled experiments and exhibits a significantly increased
frequency brought about by LPS 24H. **P = 0.007, Mann-Whitney test. c The box plot summarizes the values of τ for control and LPS; in the inset,
averaged scaled and superimposed traces of the two conditions are shown. Note that no changes were detected in IPSC decay time constant.
d Left, representative image of the LPS 24H-treated organotypic culture labeled with GFAP (green) and Iba1 (red). Right, high magnification Iba1
micrographs are shown (middle), and plots summarize the morphology changes of microglia upon LPS 24H. Note the significant increase in
dendrites length (top) and in the transformation index (bottom); ***P < 0.001, Mann-Whitney test
Giacco et al. Journal of Neuroinflammation          (2019) 16:127 Page 8 of 14
intracellular and extracellular chloride concentrations (− 50
mV; [26]). However, the reversal potential was significantly
shifted to more negative values by blocking NKCC1
(− 54.2 ± 4.3mV BUM 24H, n = 8; *P = 0.025 control vs
BUM 24H), suggesting that local intracellular chloride
concentrations are lower (estimated from 24 to 19mM). It
is important to note that in organotypic cultures, upon bu-
metanide treatments, the Cl− reversal potential differed
from the predicted theoretical value, suggesting a real shift
in the internal chloride concentration as a result of reduced
A
B
C
D
Fig. 5 Effects of CKs on GABAergic synaptic current duration in the presence of bumetanide. a Sketch of the protocol used to treat slices with
bumetanide for 24H (BUM 24H) followed by CKs 4H. b Representative traces (left) and superimposed isolated events (right) of IPSCs in control, after
BUM 24H (green), and BUM 24H + CKs 4H (magenta). c The box plot summarizes the IPSCs τ values measured in the three conditions; note the
significant reduction in IPSCs τ in BUM 24H and BUM 24H + CKs 4H, in respect to control. Inset: superimposed averaged and scaled IPSCs in the three
conditions. *P = 0.012, **P = 0.005, Kruskal-Wallis test. d Top, IPSCs averaged and superimposed traces recorded at different Vh in control (black), BUM
24H (green), and BUM 24H + CKs 4H (magenta). Bottom, I/V curves obtained by plotting GABAA-IPSCs mean amplitude against Vh. Note in the inset
the significant differences in the estimated IPSCs reversal potential (EGABA) at BUM 24H and BUM 24H + CKs 4H, when compared to control. *P < 0.05,
**P < 0.01, one-way ANOVA
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co-transport [41, 42], regardless the 24mM Cl− intracellu-
lar pipette solution [17].
Pro-inflammatory CKs, in the presence of NKCC1
block, slightly increased such a shift only when compared
to controls (− 56.2 ± 3.5mV BUM 24H + CKs 4H; n = 8;
**P = 0.003 control vs BUM 24H + CKs 4H). The absence
of significant changes in IPSC decay time constant and re-
versal once CKs were incubated in the presence of bumet-
anide might indicate an occluding mechanisms between
CKs and bumetanide in regulating [Cl−]i.
To shed light in CK potential regulation of intracellular
chloride, and thus of IPSCs τ, we estimated and compared
ECl in control, CKs, and LPS treatments. Additional file 6:
Figure S5 shows that the reversal potential of IPSCs was
not altered by these treatments alone (− 52.0 ± 7.5mV
control; − 51.5 ± 5.2mV CKs 4H; n = 9, 10, respectively; −
49.6 ± 7.8mV control; − 49.7 ± 9.9mV LPS 4H; n = 13, 8,
respectively). Regardless of the similar ECl extrapolated in
all the recording conditions, only CKs 4H induced the ex-
pected changes in the IPSC duration (τ = 31.8 ± 5.1ms
control; τ = 23.9 ± 8.1ms CKs 4H; *P = 0.031 control vs
CKs 4H; Student t test; τ = 26.4 ± 5.2ms control; τ =
26.2 ± 6.3ms LPS 4H; respectively). These results show
that changes in ECl might indeed modulate IPSC duration
in the organotypic spinal interneurons; however, CKs ap-
parently are not tuning the inhibitory current duration by
shifts in the ECl.
A well-documented post-synaptic process that changes
GABAergic inhibition is the switch in the α1-subunit ex-
pression reported to modulate IPSC kinetics, which be-
come faster [43]. To address the potential changes in the
receptor subunit composition due to CK treatment, we
tested IPSC kinetics in the presence of zolpidem (100
nM; 15–20 min), an allosteric modulator of GABAAR
subunits that at low concentrations is highly selective for
the GABAAR α1 subunit [44]. Figure 6a shows sample
superimposed isolated IPSCs recorded from control,
CKs 4H, and CKs 6H, before and after zolpidem applica-
tions. Also, in this set of recordings, after CKs 4H and
6H, IPSCs τ was significantly reduced (33.3 ± 4.5 ms con-
trol; 25.4 ± 4.7 ms CKs 4H; 26.0 ± 4.0 ms CKs 6H; n = 9,
10, 9, respectively; *P = 0.019 control vs CKs 4H; *P =
0.045 control vs CKs 6H). Subsequent applications of
zolpidem did not alter IPSCs τ in control (36.3 ± 3.9 ms),
while significantly prolonged τ values detected in CKs
4H and 6H (34.5 ± 6.9 ms CKs 4H; 34.2 ± 6.0 ms CKs
A
B
Fig. 6 Zolpidem effects on GABAergic synaptic current duration before and after CK treatments. a Sample tracings of averaged IPSCs recorded in
control (black) and CKs (4H in gray and 6H in blue) in the presence (+) or in the absence (−) of zolpidem. Note the superimposed fitting used to
calculate τ values. b Bar plot summarizes the τ values of IPSCs in control, CKs 4H, and CKs 6H, before and after bath application of zolpidem. Note
that the significant decrease in IPSCs τ upon CKs treatments (4H and 6H) was reversed by zolpidem. *P < 0.05, **P < 0.01, one-way ANOVA
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6H; **P = 0.003 CKs 4H − Zolpidem vs CKs 4H + zolpi-
dem; *P = 0.017 CKs 6H -zolpidem vs CKs 6H + zolpi-
dem), which did not differ anymore from control IPSCs
(summarized in the bar plots of Fig. 6 B). These results
strongly suggest that CK treatments regulated the dur-
ation of GABAergic inhibition via post-synaptic changes
of the α1 subunit.
Discussion
Our study targets synaptic changes in response to local
CNS tissue reactivity, experimentally induced by CKs or
LPS and involving resident neuroglia. In particular, we used
the spinal organotypic cultures to focus on the interplay be-
tween local inflammation and the dynamics of GABAergic
currents, whose altered decay may represent a subtle alter-
ation able to trigger neuronal network dysfunction, poten-
tially involved in neurodegenerative processes [45–47]. The
organotypic slice model represents a high-density cell sys-
tem, where the 3D-architecture of specific resident cells,
neuronal and non-neuronal, is preserved in a tissue culture
setting [15–17, 48]. The main finding of the current work is
that local inflammation in organotypic spinal slices induced
by CKs and LPS stimulations boosts network activity
already after 4H treatments, as shown by the augmented
PSCs and IPSCs frequency; however, only tissue reactivity
brought about by CKs specifically reduced GABAergic
current duration. We adopted short-term treatments to
trigger inflammatory responses, without affecting neuronal
membrane properties or inducing direct neurotoxicity, yet
still able to alter synaptic transmission [17, 49].
The ability of CKs, directly, or of LPS-activated immune
cells, indirectly, to increase synaptic activity or neuronal
excitability has been previously described using several ex-
perimental settings and in different CNS structures [5, 17,
30, 31, 50, 51]. Yet, mechanistically, the influence on syn-
aptic function of acute or prolonged exposures to inflam-
matory milieus has led often to controversial results,
involving the glutamatergic signaling system [6, 52, 53], or
the inhibitory synaptic transmission [5, 30, 54], as well as
neuronal excitability [31, 50, 55], clearly indicating the
complexity of the signaling pathways activated upon in-
flammation. In addition, the output readout used in these
studies, i.e., post-synaptic currents, might be misleading,
due to the variable amount of homeostatic plasticity tak-
ing place once destabilizing influences alter synaptic trans-
mission [56]. Regardless the mechanisms leading to
improved synaptic activity, only the direct exposure to
CKs regulated the GABAergic current decay, probably via
a post-synaptic mechanisms, as indicated by the detected
changes in mIPSC’s τ [26, 57]. The absence of LPS ability,
even upon prolonged exposure of the slices, to regulate
the inhibitory current decay was apparently not due to a
lack of LPS activation of inflammation, a notion supported
by the LPS-mediated increase in synaptic activity and by
the cytokines and chemokines produced by LPS-treated
slices, despite the low GFAP-positive cell reactivity and
the changes in microglia morphology detected by im-
munocytochemistry, different to those reported in CKs.
To note, the morphology of resident neuroglia together
with the small increase in GFAP expression upon LPS
treatment may indicate a different state of activation, sup-
ported by a different profile of CK network and produc-
tion, providing an alternative (i.e., to CKs), inflammation-
mediated regulation of brain functions [35, 58]. LPS is
experimentally used to mimic CNS bacterial inflam-
mation [59], whereas CKs mimic the inflammatory
network present when immune system intervenes in
the CNS. These two functional conditions may affect
synapses differently, and future investigations may
allow elucidating CNS pathological conditions related
to distinct etiologies. Indeed, we have to consider the
diverse mechanisms of action triggered by CKs and
LPS [60–63] which both act through precise receptors
on microglia and neurons, affecting the microglia/
neuron communication and function [64].
CK regulation of GABAergic current in the absence of
changes in GABA synthesis is thus a specific feature of
the selected CK cocktail, able to mimic an inflammatory
reaction involved in neuropathy [2, 6, 17], and the mech-
anisms of this modulation might be a targetable pathway
in spinal neuroinflammatory disease treatments.
We examined the main variables that might conceiv-
ably affect the kinetic properties of GABAAR and there-
fore the GABAergic-PSC time course. First, we excluded
the possibility of differences in the intracellular chloride
concentration, brought about by neuroinflammation [38,
65] that could affect IPSC kinetics [66], as confirmed by
our experiments where NKCC1 was pharmacologically
blocked, leading to a shift in Cl− reversal potential. Our
measurements show that the Cl− reversal potential was
similar in the cultures treated by CKs or LPS, in the ab-
sence of bumetanide, yet CKs still induced a significant
shortening of the GABAergic current duration. In
bumetanide-treated cultures, the Cl− reversal potential
differed from the predicted theoretical value. In our re-
cording conditions, it is not possible to confirm a real
shift in the internal chloride concentration as a result of
the decreased influx [41, 42]. However, the detected
shifts in bumetanide are consistent with a 19mM Cl−
intracellular concentration.
An alternative process that changes IPSC current dur-
ation in the CNS is the GABAAR α-subunit composition
[39, 67–69]. In particular, α1-subunit is responsible for
fast deactivation, which results in faster-decaying cur-
rents [39, 69]. Our hypothesis, of an increased expres-
sion of α1-subunit upon CKs treatment, was supported
by the efficacy of zolpidem [44] to prolong IPSC dur-
ation only in CK-treated slices.
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Our results describe for the first time a selective mech-
anism that could be triggered during inflammatory stress.
In particular, under pathological conditions, the switch of
GABAAR α1-subunit would induce faster GABAAR decay
time, weakening the IPSCs transmission. Therefore, lower
IPSC duration could contribute to providing an aberrant
excitatory transmission critical for pre-motor circuit tasks.
Conclusions
We exploited spinal cord explant cultures to investigate
two diverse immune conditions in the CNS, character-
ized by different inflammatory networks and products,
thus providing alternative inflammation-mediated regu-
lation of the CNS functions. We have shown that these
two functional conditions affect inhibitory synapses dif-
ferently, and we hypothesized that the mechanisms of
this modulation might be a targetable pathway in spinal
neuroinflammatory disease treatments.
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Additional file 1: Table S1. Neuroglial cell reactivity upon 4-h treat-
ments in CKs and LPS. (PDF 1613 kb)
Additional file 2: Figure S1. CKs and LPS increase sPSC frequency in
organotypic slices A-B, Representative current tracings of sPSCs recorded
in control (black) and after incubation in CKs (4H in gray and 6H in blue;
left) or in LPS (4H in gray and 6H in blue; right). C-D, Box plots summarize
the increase in sPSC frequency (20.3 ± 9.5 Hz control; 27.9 ± 9.4 Hz CKs 4H;
28.8 ± 9.4 Hz CKs 6H; ***P < 0.001 control vs CKs 4H and control vs CKs
6H, one-way ANOVA) and in LPS (21.4 ± 9.7 control; 28.4 ± 10.4 LPS 4H;
33.3 ± 9.8 LPS 6H; **P = 0.008 control vs LPS 4H; ***P < 0.001 control vs
LPS 6H, one-way ANOVA) treatments. (PDF 37 kb)
Additional file 3: Figure S2. CKs and LPS increase IPSC frequency in
organotypic slices A–C. Box plots illustrate the mean value of IPSCs
frequency (A), amplitude (B), and rise time (C) upon CK and LPS
treatments. A significant increase was observed in the IPSC frequency at
CKs 4H and 6H, when compared to control (3.3 ± 1.5 Hz control; 4.7 ± 1.9
Hz CKs 4H; 4.6 ± 2.0 Hz CKs 6H; n = 40, 33, 37, respectively; **P = 0.003
control vs CKs 4H and **P = 0.006 vs CKs 6H, one-way ANOVA) and at LPS
4H and 6H when compared to their relative control (1.7 ± 0.9 Hz control;
3.1 ± 2.6 Hz LPS 4H; 3.4 ± 2.7 Hz LPS 6H; n = 34, 33, 27, respectively;
*P = 0.002, control vs LPS 4H, and **P = 0.001 vs LPS 6H, one-way
ANOVA). IPSC amplitude (17.5 ± 10.5 pA control; 19.4 ± 9.1 pA CKs 4H;
17.0 ± 11.2 pA CKs 6H; 15.7 ± 8.9 pA control; 11.3 ± 4.5 pA LPS 4H; 13.1 ±
7.3 pA LPS 6H) and rise time (2.5 ± 0.8 ms control; 2.1 ± 0.8 ms CKs 4H;
2.6 ± 1.4 ms CKs 6H; 2.6 ± 1.0 ms control; 2.5 ± 1.0 ms LPS 4H; 2.6 ± 0.9 ms
LPS 6H) were unaffected by CK or LPS treatments. (PDF 6885 kb)
Additional file 4: Figure S3. GAD65/67 immunoreactivity in
organotypic slices before and after CK or LPS treatments A and C.
Representative images of spinal slices labeled for β-tubulin III (in blue)
and GAD65/67 (in red) show GABAergic neurons in untreated (control)
and CK- and LPS-treated (4H and 6H) ventral area of spinal organotypic
slices (14 DIV) B and D. Bar plots summarize the normalized GAD65/67
clusters (1483 ± 62.2 control; 1503 ± 49.9 CKs 4H; 1403 ± 27.2 CKs 6H;
1295 ± 45.3 control; 1300 ± 46.3 LPS 4H; 1382 ± 54.4 LPS 6H) and the
GAD65/67 intensity in a.u. (379.1 ± 29.4 control; 423.9 ± 40.8 CKs 4H;
383.9 ± 38.5 CKs 6H; 417.3 ± 46.9 control; 391.3 ± 58.4 LPS 4H; 433.3 ± 46.5
LPS 6H). (PDF 28 kb)
Additional file 5: Figure S4 Spontaneous PSC and IPSC frequency in
bumetanide 24 h before and after CKs 4H. A Left, box plots of PSCs
frequency values from control, bumetanide-treated slices prior and after
CKs. Note the significant increase in PSC frequency BUM 24H and BUM
24H + CKs 4H compared to control (24.4 ± 7.8 Hz control; 37.1 ± 11.4 Hz
BUM 24H; 42.6 ± 11.2 Hz BUM 24H + CKs 4H; n = 9, 10, 9, respectively;
*P = 0.033 control vs BUM 24H; **P = 0.003 control vs BUM 24H + CKs 4H,
one-way ANOVA). Right, box plots of IPSCs frequency values upon BUM
24H and BUM 24H + CKs 4H compared to control (3.1 ± 1.4 Hz control;
6.0 ± 2.8 Hz BUM 24H; 6.6 ± 2.5 Hz BUM 24H + CKs 4H; n = 10, 11, 10,
respectively; *P = 0.019 control vs BUM 24H; **P = 0.005 control vs BUM
24H + CKs 4H, one-way ANOVA). (PDF 278 kb)
Additional file 6: Figure S5. EGABA estimated in control, CKs 4H and
LPS 4H. IPSCs averaged and superimposed traces (top) recorded at
different Vh in control, CKs 4H, and LPS 4H. Bottom, I/V curves were
obtained by plotting GABAA-PSCs mean amplitude against Vh. Inset, note
the similar (EGABA) in all conditions. *P < 0.05, **P < 0.01, one-way ANOVA.
(PDF 13 kb)
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